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lar disease at baseline and in response to acute mental stress to establish a brain–heart link. In 409
black and white South Africans, brain-derived neurotrophic factor (BDNF) and fibrinolytic measures
were assessed at baseline. Glial cell-derived neurotrophic factor (GDNF), S100 calcium-binding protein
(S100B), von Willebrand factor (VWF), fibrinogen and D-dimer were assessed at baseline and 10 min
after the Stroop test. Neurotrophins were regressed on hemostatic measures adjusting for demograph-
ics, comorbidities, cardiometabolic factors and health behaviors. Higher baseline BDNF was associated
with greater stress-induced increase in fibrinogen (<jats:italic>p</jats:italic> = 0.003) and lower D-
dimer increase (<jats:italic>p</jats:italic> = 0.016). Higher baseline S100B was significantly asso-
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increases were associated with lower VWF increase. All associations showed small-to-moderate effect
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Circulating neurotrophins 
and hemostatic risk factors 
of atherothrombotic 
cardiovascular disease at baseline 
and during sympathetic challenge: 
the SABPA study
Roland von Känel1,2*, Mark Hamer3, Annemarie Wentzel2 & Leoné Malan2
Sympathetic activation may trigger acute coronary syndromes. We examined the relation between 
circulating neurotrophic factors and hemostatic risk factors of atherothrombotic cardiovascular 
disease at baseline and in response to acute mental stress to establish a brain–heart link. In 409 
black and white South Africans, brain-derived neurotrophic factor (BDNF) and fibrinolytic measures 
were assessed at baseline. Glial cell-derived neurotrophic factor (GDNF), S100 calcium-binding 
protein (S100B), von Willebrand factor (VWF), fibrinogen and D-dimer were assessed at baseline and 
10 min after the Stroop test. Neurotrophins were regressed on hemostatic measures adjusting for 
demographics, comorbidities, cardiometabolic factors and health behaviors. Higher baseline BDNF 
was associated with greater stress-induced increase in fibrinogen (p = 0.003) and lower D-dimer 
increase (p = 0.016). Higher baseline S100B was significantly associated with higher baseline VWF 
(p = 0.031) and lower fibrinogen increase (p = 0.048). Lower baseline GDNF was associated with higher 
baseline VWF (p = 0.035) but lower VWF increase (p = 0.001). Greater GDNF (p = 0.006) and S100B 
(p = 0.042) increases were associated with lower VWF increase. All associations showed small-to-
moderate effect sizes. Neurotrophins and fibrinolytic factors showed no significant associations. 
The findings support the existence of a peripheral neurothrophin-hemostasis interaction of small-
to-moderate clinical relevance. The implications for atherothrombotic cardiovascular disease need 
further exploration.
Fueling the scientific bases of a brain–heart link, there is accumulating evidence for a role of circulating neu-
rotrophic factors (a.k.a. neurotrophins), such as brain-derived neurotrophic factor (BDNF) and S100 calcium-
binding protein B (S100B), in atherothrombotic cardiovascular disease (CVD). For instance, low serum levels of 
BDNF were found in patients with stable coronary heart disease (CHD) versus non-CHD  controls1 and BDNF 
was associated with incident CHD in the Framingham  study2. Compared to those with stable CHD, patients 
with unstable CHD showed elevated BDNF levels in the coronary circulation and greater expression of BDNF 
in coronary arteries, suggesting that BDNF is critically involved in atherogenesis and plaque  instability3. Serum 
levels of S100B, indicating neuroinflammation and increased blood brain barrier  permeability4, were higher in 
patients with acute coronary syndrome (ACS) than in patients with stable  CHD5. Moreover, serum S100B levels 
showed direct correlations with cardiac enzyme levels in ACS patients and with infarct size in a rat model of 
cardiac ischemia–reperfusion  injury5. Another emerging neurotrophin is glial cell-derived neurotrophic factor 
(GDNF) with lower levels possibly being associated with metabolic factors relevant to CVD  risk6.
Alterations in the hemostatic system with respect to a hypercoagulable state play a pivotal role in the initia-
tion, progression and clinical manifestation of atherothrombotic  diseases7–9. Hemostatic factors such as elevated 
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plasma levels of von Willebrand factor (VWF), fibrinogen, fibrin D-dimer and plasminogen activator inhibitor 
(PAI)-1 have been associated with an increased risk of CHD, independent of traditional risk factors of  CVD10–12. 
Although it is increasingly acknowledged that the brain and the hemostatic system do not function in isola-
tion from each  other13, research on associations between neurotrophins and hemostatic factors in the human 
circulation is still in its infancy. Such studies could help to elucidate mechanisms involved in the brain–heart 
link relevant to atherosclerosis. Two previous studies in patients with CHD showed inverse associations of 
BDNF with  fibrinogen14 and  VWF2. The latter suggests a link between BDNF and VWF in endothelial dysfunc-
tion, a key mechanism in atherosclerosis. Indeed, BDNF promotes vascular endothelial cell integrity but it is 
also directly released from endothelial  cells15 and VWF is a marker of endothelial cell  injury16. BDNF is also 
required for intramyocardial vessel stabilization, which are compromised in CHD and  ACS15. Similarly, it has 
been suggested that circulating S100B could contribute to endothelial cell dysfunction, based on a positive 
association between S100B and VWF levels observed in patients with multiple  trauma17. In vitro, lower levels 
of recombinant human BDNF were correlated with more rapid clotting and longer clot lysis, resulting in the 
formation of larger  thrombi18.
The pathophysiology of ACS triggering, for instance through strenuous exercise and emotional  stress19, 
involves sympathetically induced activation of the coagulation  system20. The VWF, mediating platelet adhe-
sion and aggregation in  ACS21, fibrinogen and D-dimer, indicating fibrin formation, although not PAI-1, have 
been shown to be acute stress-responsive hemostatic  factors22. Circulating levels of BDNF and S100B were also 
found to be responsive to acute mental stress in  humans23 and to restraint stress in  rats24, respectively. Studies 
on whether circulating levels of neurotrophins, both at baseline and during stress, are associated with stress-
induced hypercoagulability could provide new insight into the pathophysiology of the brain–heart link in ACS.
The primary aim of this study was to investigate the association between circulating levels of BDNF, S100B and 
GDNF with hemostatic factors reflecting endothelial function/integrity, coagulation activation, and fibrinolysis 
both at baseline and during sympathetic challenge in a cohort of urban black and white teachers from South 
Africa. In this cohort, we previously reported that compared to whites, blacks had lower baseline BDNF  levels25, 
higher hemostatic factors indicative of a baseline-procoagulant  state26 and lower hemostatic stress  reactivity27. 
Therefore, and as cardiovascular burden is projected to rapidly increase in black Africans from sub-Saharan 
urban  regions28, a secondary aim of this study was to examine whether the relationship between neurotrophic 
and hemostatic measures would differ between blacks and whites at baseline and in response to mental stress.
We hypothesized that BDNF levels (measured at baseline only) would show an inverse association with 
hemostatic factors of a hypercoagulable state at baseline and in response to stress, adjusting for important demo-
graphic and health characteristics known to affect hemostasis. However, due to the scant available literature, we 
considered all other analyses exploratory regarding the direction of a relationship between neurotrophic and 
hemostatic factors and the role of ethnicity therein.
Methods
Participants. Study participants were recruited as part of the Sympathetic Activity and Ambulatory Blood 
Pressure in Africans (SABPA) study between 2/2008 and 5/200929. The study protocol, conducted in accordance 
with the Declaration of Helsinki, was approved by the Ethics Review Board of the North-West University, Potch-
efstroom Campus. All participants provided written informed consent. The SABPA study had a target sample of 
409 teachers to assure similar socio-economic class, aged 25–65 years, and working in the Dr Kenneth Kaunda 
Education district in the North West Province, South Africa. To increase generalizability of study findings, we 
analysed the data of the entire cohort, but made statistical adjustment for health characteristics as potentially 
important confounders.
Procedures. On the same day, Monday through Thursday, all participants were equipped with a 24-h ambu-
latory BP measurement device between 7:00 and 8:00 am at their respective schools and admitted to the Meta-
bolic Unit Research Facility of the North-West University at 5:00 pm. They completed questionnaires for an 
assessment of demographic data, general health and health behaviors. A standardized dinner was served at 
6:30 pm. A last snack with beverages was provided at 8:30 pm. Afterwards participants engaged in recreational 
activities before going to bed at 10:00 pm. They were woken at 5:45 am. Anthropometric measurements were 
obtained, the ambulatory BP monitor was removed, and fasting blood samples were collected to determine rou-
tine laboratory parameters and neurotrophic factors. A sterile winged infusion set was left in situ with a heparin 
block to prevent clotting. After a standardized breakfast, participants underwent a standardized laboratory stress 
procedure.
Stress protocol. Participants were administered the Stroop Color-Word Conflict test to induce mental 
stress, which provokes reproducible cardiovascular  reactivity30 and hemostatic  activation31. For one minute, 
words on a cardboard describing a specific color, but written in different colors, were shown to participants. 
They were asked to verbally indicate the ink color of a given word but not to read the color represented by the 
word. In order to increase the stress/ challenge level, participants were asked to progress as fast as possible and to 
correct answers that were wrong; they received a monetary incentive according to their performance on comple-
tion of the task. To determine cardiovascular reactivity, beat-to-beat BP and heart rate were recorded with the 
Finometer device at baseline and during stress (Finapres Medical Systems, Amsterdam, the Netherlands). For 
this purpose, the average of the recordings of the last minute of the 5-min baseline phase and of the last 20 s of 
the 1-min stress phase was calculated. To determine hemostatic reactivity, citrated blood samples to assay hemo-
static factors were collected immediately before the Stroop test and 10 min thereafter.
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Measures. Neurotrophic factors. Serum BDNF was analyzed with a Quantikine Colorometric Sandwich 
Immunoassay (R&D Systems, USA & Canada; catalogue number: DBD00) with intra‐ and inter-assay coeffi-
cients of variation (CV) < 7% and 12%, respectively. Serum GDNF was determined with the Human GDNF Duo-
Set ELISA kit (R&D Systems, USA & Canada; catalogue number DY212) with intra- and inter-assay CV < 9%. 
Serum S100B was measured with an electrochemiluminescence immunoassay on the automated Cobas e411 
(Roche, Basel, Switzerland) with intra- and inter-assay CV < 5%. All samples were analyzed in duplicates.
Hemostatic factors. Fibrinogen was determined with a viscosity-based method and D-dimer with the STA-Liat-
est D-di immunoturbidimetric assay (STA Compact, STAGO Diagnostic, Roche, Asnières, France). ELISA kits 
were used to quantify PAI-1(TriniLIZE PAI-1 Antigen, Trinity Biotech, Bray, Ireland) and VWF antigen (anti-
bodies from DAKO, Gauteng, South Africa). Clot lysis time (CLT) was measured with a turbidimetric  method32. 
Intra- and inter-assay CV were < 10% for all hemostatic assays. All samples were analyzed in duplicates.
Covariates. Collection of self-reported data included information on ethnicity, sex, age and history of stroke 
and myocardial infarction. Human immunodeficiency virus (HIV) infection was investigated with a rapid anti-
body test in plasma (First Response Kit; PMC Medical, Daman, India) and confirmed with the Pareekshak test 
(BHAT Bio-Tech, Bangalore, India). With participants in their underwear, height and weight were measured 
to the nearest 0.1 cm and 0.1 kg to calculate the BMI. Hemoglobin A1c (HbA1c) was determined from EDTA 
whole blood samples with a turbidimetric inhibition immunoassay using the Roche Integra 400 (Roche, Basel, 
Switzerland). High-sensitivity C-reactive protein (CRP), γ-glutamyl transferase (GGT), total cholesterol (T-C) 
and high-density lipoprotein cholesterol (HDL-C), were measured in serum with two sequential multiple ana-
lyzers (Konelab 20i, Thermo Scientific, Vantaa, Finland; Unicel DXC 800, Beckman and Coulter, Munich, Ger-
many). A categorical variable with CRP ≤ 3 mg/L, 3–10 mg/L and > 10 mg/L, indicating different CVD risk, was 
formed and used as a covariate. Levels of GGT were categorized as < 41 IU/L vs. ≥ 41 IU/L as a marker of chronic 
excessive alcohol  consumption33. As an index of dyslipidemia, the T-C/HDL-C ratio was used as a covariate. 
Ambulatory BP was monitored with the Cardiotens apparatus (CE0120, Meditech, Budapest, Hungary) over 
24 h with 30-min intervals during the day (8:00 am to 10 pm) and 60-min intervals during the night (89% mean 
successful inflation rate). Mean 24-h arterial pressure, an integrative measure of systolic and diastolic BP, was 
calculated with the formula [2/3(diastolic BP) + 1/3 (systolic BP)] and used as a covariate. Estimated glomerular 
filtration rate (eGFR) was computed with the 4-variable MDRD formula considering serum creatinine, age, eth-
nicity and  sex34. Current smoking was determined based on self-report and/or serum cotinine levels analyzed by 
an accredited pathology lab (AMPATH, Pretoria, Gauteng, South Africa) with the Modular Roche Automated 
Analyser (Basel, Switzerland). Actical accelerometers (Montréal, Québec, Canada) worn over a 7 d monitoring 
period were used to form a categorical variable of light, moderate or vigorous physical  activity35.
Statistical analysis. Data were analyzed using SPSS version 25 (SPSS, Chicago, IL) with level of signifi-
cance set at p < 0.05 (two-tailed). We did not adjust p-values for multiple comparisons, but show effects sizes of 
relationships. Reasons for this were a) the exploratory nature of our study in a nascent research area bearing the 
risk of deeming truly important relationships non-significant, and b) indication of the same biological process 
(i.e. hemostatic function) of outcome  variables36,37. Effect sizes were expressed as Cohen’s d with 0.2, 0.5, and 
0.8 indicating small, medium and large effects,  respectively38. We also report on main effects with borderline 
significance (p < 0.10) to show trends that may additionally help pattern recognition of a brain-hemostasis cross-
talk. Due to skewed distributions, values of neurotrophins and hemostatic factors were log transformed before 
the analyses. Several variables had missing values (< 5% for each of these variables) which were replaced with 
the expectation maximization algorithm (see supplementary information for numbers of missing values). Log 
baseline values, log post-stress values and stress-induced percent changes in neurotrophins and hemostatic fac-
tors that were three standard deviations above or below the sample mean were considered outliers (see supple-
mentary information for number of outliers). The participants with these outliers were excluded in correlation 
analyses, repeated measure analyses of variance and regression models. For these analyses with D-dimer as an 
outcome, two participants on oral anticoagulants, lowering D-dimer levels, were also excluded.
Characteristics of black and white South Africans were compared with t-tests for continuous variables and 
with chi‐square tests for categorical variables. Pearson correlations were used to analyze the strength of the 
relationship between neurotrophins and hemostatic factors. Stress reactivity of cardiovascular parameters, hemo-
static and neurotrophic factors was tested with repeated measure analysis of variance. Hierarchical regression 
analysis, using forced entry for blocks of covariates, was employed to identify whether neurotrophic measures 
would significantly be linked with hemostasis measures, independent of covariates, both at baseline and dur-
ing acute mental stress. For the latter analysis, stress-induced changes in neurotrophins and hemostatic factors 
were calculated as percent change from baseline values. Covariates in each block of the regression models were 
selected a priori, based on the literature, as they might potentially confound associations with hemostatic factors: 
(a) ethnicity; (b) demographic factors: sex and age; (c) comorbidities: HIV positive status and atherothrombotic 
disease history; (d) metabolic factors: BMI, HbA1c, T-C/HDL-C, mean 24-h arterial pressure, eGFR and CRP 
categories; (e) health behaviors: current smoking, physical activity and excessive alcohol consumption. Bar 
graphs across quartiles of either baseline values or stress-induced percent changes in neutrophins were drawn 
to illustrate associations of neurotrophins that were found to be significant in fully adjusted models. As a com-
plementary analysis, we additionally entered interaction terms between ethnicity and neurotrophic measures 
to explore whether the relationship between neurotrophic and hemostatic measures would significantly differ 
in black from white South Africans. Regression outputs were verified for the absence of multicollinearity and 
influential outliers in the set of predictor variables with Cook’s distance.
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Results
Participant characteristics. Table 1 shows that with the exception of the distributions of sex, age and 
atherothrombotic diseases, all other variables were significantly different between blacks and whites. Blacks had 
a worse CVD risk profile in terms of most metabolic factors and adverse health behaviors. Relative hypercoagu-
lability was evident in blacks with higher levels of hemostatic factors indicating prothrombotic activity and lower 
levels of measures indicating fibrinolytic activity. In terms of neurotrophins, BDNF and GDNF levels were lower 
and S100B level was higher in blacks than whites.
Neurotrophins and hemostatic factors at baseline. Several significant correlations emerged between 
baseline levels of the five hemostatic factors (all p-values < 0.001). There were direct associations of VWF 
with fibrinogen (r = 0.27), D-dimer (r = 0.25), PAI-1 (r = 0.40) and CLT (r = 0.20); of fibrinogen with D-dimer 
(r = 0.28), PAI-1 (r = 0.17) and CLT (r = 0.20); and of PAI-1 with CLT (r = 0.43). As per associations between 
baseline levels of neurotrophins, there was an inverse correlation between GDNF and S100B levels (r = − 0.19, 
p < 0.001); BDNF levels showed no significant correlation with GDNF and S100B levels.
The regressions of baseline values of neurotrophins on hemostatic factors, subsequently adjusted for blocks of 
covariates, are summarized in Table 2. Fully adjusted models showed significance for VWF, which was inversely 
associated with GDNF (p = 0.035, d = 0.21) (Fig. 1a) and positively associated with S100B (p = 0.031, d = 0.22) 
(Fig. 1b). Also in the fully adjusted model, a trend towards significance was seen for longer CLT with higher 
S100B levels (p < 0.06, d = 0.19). Ethnicity-adjusted significant associations of BDNF with fibrinogen (p = 0.001, 
d = 0.35), D-dimer (p = 0.035, d = 0.21) and PAI-1 (p = 0.040, d = 0.20) became non-significant with further adjust-
ment for sex and age. The unadjusted significant and direct associations of S100B with fibrinogen (p = 0.001, 
d = 0.33), D-dimer (p = 0.041, d = 0.20), PAI-1 (p < 0.001, d = 0.47) and CLT (p = 0.046, d = 0.20) became non-
significant with adjustment for ethnicity. Likewise, the unadjusted significant and inverse association of GDNF 
with PAI-1 (p = 0.020, d = 0.24) and of GDNF with CLT (p < 0.07, d = 0.19), showing borderline significance, 
became both non-significant with adjustment for ethnicity. In complementary analyses, adjusting for all covari-
ates, all interaction terms between ethnicity and neurotrophic measures turned out to be non-significant (data 
not shown).
Table 1.  Characteristics of all study participants and compared between black and white South Africans. 
Values are percentages or median with inter-quartile range.
Variables All (n = 409) Blacks (n = 200) Whites (n = 209) p (groups)
Female sex, n 207 (50.6) 99 (49.5) 108 (51.7) 0.660
Age, years 45 (38.0–52.0) 44 (28.0–51.0) 47 (38.5–53.0) 0.495
Human immunodeficiency virus positive status, n 19 (4.6) 19 (9.5) 0 (0)  < 0.001
Atherothrombotic disease, n 5 (1.2) 2 (1.0) 3 (1.4) 1.000
Body mass index, kg/m2 27.7 (24.2–32.0) 29.8 (24.9–34.0) 26.9 (23.6–30.3)  < 0.001
Hemoglobin A1c, % 5.60 (5.30–5.90) 5.76 (5.50–6.20) 5.40 (5.20–5.70)  < 0.001
Total-cholesterol / high-density lipoprotein-cholesterol, 
ratio
4.33 (3.49–5.76) 4.03 (3.26–5.10) 4.74 (3.64–6.24) 0.005
Mean 24-h arterial pressure, mmHg 94.7 (88.3–101.3) 98.8 (90.7–107.7) 91.7 (86.2–97.0)  < 0.001
Estimated glomerular filtration rate, mL/min/1.73m2 101. 4 (86.5–116.7) 112.6 (93.5–129.7) 94.0 (83.2–106.0)  < 0.001
High-sensitivity C-reactive protein
 ≤ 3 mg/L, n 218 (53.3) 69 (34.5) 149 (72.0)
 < 0.0013–10 mg/L, n 136 (33.3) 85 (42.5) 51 (24.6)
 > 10 mg/L, n 55 (13.4) 46 (23.0) 9 (4.4)
Current smokers, n 75 (18.3) 50 (25.0) 25 (12.1) 0.001
Physical activity, intensity
Light, n 252 (61.6) 147 (73.5) 105 (50.7)
 < 0.001Moderate, n 120 (29.3) 42 (21.0) 78 (37.7)
Vigorous, n 37 (9.0) 11 (5.5) 26 (12.6)
Excessive alcohol consumption, n 131 (32.0) 102 (51.0) 29 (14.0)  < 0.001
Brain-derived neurotrophic factor, ng/mL 1.45 (1.07–1.84) 1.33 (0.91–1.79) 1.53 (1.17–1.87)  < 0.001
Glia cell-line derived neurotrophic factor, pg/mL 25.2 (17.2–92.7) 21.3 (16.5–44.2) 37.0 (18.7–243)  < 0.001
S100 calcium-binding protein, µg/L 0.041 (0.031–0.058) 0.050 (0.036–0.069) 0.038 (0.029–0.046)  < 0.001
von Willebrand factor, % 72.6 (59.3–91.5) 88.8 (76.9–108.0) 60.9 (54.1–70.1)  < 0.001
Fibrinogen, g/L 3.16 (2.77–3.67) 3.45 (2.89–3.98) 2.97 (2.66–3.44)  < 0.001
D-dimer, ng/mL 260 (167–410) 305 (183–458) 230 (134–324)  < 0.001
Plasminogen activator inhibitor-1, ng/mL 27.2 (20.4–35.4) 35.2 (27.1–42.3) 21.3 (16.0–27.3)  < 0.001
Clot lysis time, min 77.7 (69.6–86.0) 80.5 (73.0–82.8) 74.7 (68.2–82.8)  < 0.001
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Stress reactivity. Across all participants, the Stroop provoked marked cardiovascular reactivity with 
increases (mean ± SD) in heart rate from 67 ± 11 bpm to 88 ± 16 bpm, in systolic BP from 138 ± 17 mmHg to 
156 ± 21 mmHg, and in diastolic BP from 79 ± 10 mmHg to 89 ± 11 mmHg (all p-values < 0.001). Table 3 shows 
mean values of neurotrophic and hemostatic factors at baseline, after stress and as stress-induced percent changes 
after outliers had been removed. In all participants, there was a significant increase in VWF (p < 0.001) and a sig-
nificant decrease in fibrinogen (p < 0.0.001), but no change in D-dimer (p = 0.87). Compared with whites, blacks 
showed a smaller increase in VWF as well as a greater decrease in fibrinogen from baseline to stress. Regarding 
neurotrophins, there was a significant decrease in both GDNF (p < 0.001) and S100B (p = 0.045) from base-
line to stress in all participants. GDNF reactivity was significantly greater in whites, whereas S100B reactivity 
was significantly greater in blacks compared with their respective ethnic counterparts. After outlier values had 
been removed, median (range) for stress-induced percent changes were − 1.2% (− 67.1–58.3) for GDNF, 0.6% 
(− 21.0–21.3) for S100B, 4.0% (− 15.3–34.3) for VWF, − 6.9% (− 49.6–22.7) for fibrinogen and 0.7% (− 53.2–59.9) 
for D-dimer.
Neurotrophins at baseline and hemostatic factors in response to stress. The regressions of base-
line values of neurotrophins on stress-induced changes in hemostatic factors, subsequently adjusted for blocks 
of covariates, are summarized in Table 4. In fully adjusted models, higher baseline BDNF was significantly asso-
ciated with less fibrinogen decrease (p = 0.003, d = 0.30) (Fig. 2a) and with lower D-dimer increase (p = 0.016, 
d = 0.25) (Fig. 2b) and, with borderline significance, with VWF (p < 0.09, d = 0.18). Higher baseline GDNF was 
significantly associated with greater VWF increase (p = 0.001, d = 0.35) (Fig. 2c). Greater baseline S100B was 
significantly associated with greater fibrinogen decrease (p = 0.048, d = 0.20) (Fig. 2d) and, with borderline sig-
Table 2.  Regression models for the associations between neurotrophins and hemostatic factors at baseline. 
BDNF, brain-derived neurotrophic factor; CLT, clot lysis time; GDNF, glia cell-line derived neurotrophic 
factor; PAI, plasminogen activator inhibitor; S100B, S100 calcium-binding protein B; VWF, von Willebrand 
factor. Unstandardized coefficients B (95% confidence interval) indicate associations between (log) 
neurotrophic and hemostatic factors with subsequent adjustment for blocks of covariates. Significance level: 
(*)p < 0.10, * p < 0.05, ** p < 0.01, *** p < 0.001. Comorbidities: Human immunodeficiency virus positive status, 
history of atherothrombotic disease. Metabolic factors: Body mass index, hemoglobin A1c, total cholesterol 
to high-density lipoprotein cholesterol ratio; mean 24-h arterial pressure, estimated glomerular filtration rate, 
high-sensitivity C-reactive protein. Health behaviors: Current smoking, physical activity, excessive alcohol 
consumption.
Variables entered Log VWF [%] Log fibrinogen [g/L]
Log D-dimer [ng/
mL] Log PAI-1 [ng/mL] Log CLT [min]
Log BDNF [ng/mL]
− 0.038 (− 0.101, 
0.024)
0.047 (0.003, 0.091)* 0.104 (− 0.055, 0.264)
− 0.162 (− 0.239, 
− 0.085)***
− 0.032 (− 0.069, 
0.004)(*)




− 0.065 (− 0.127, 
− 0.003)*
− 0.017 (− 0.053, 
0.020)
 + sex, age 0.022 (− 0.032, 0.077) 0.030 (− 0.013, 0.072) 0.086 (− 0.080, 0.252)
− 0.025 (− 0.090, 
0.039)
0.004 (− 0.033, 0.042)
 + comorbidities 0.025 (− 0.030, 0.079) 0.028 (− 0.014, 0.070) 0.082 (− 0.084, 0.248)
− 0.024 (− 0.089, 
0.041)
0.004 (− 0.034, 0.042)
 + metabolic factors 0.019 (− 0.035, 0.073) 0.010 (− 0.026, 0.046) 0.062 (− 0.100, 0.224)
− 0.032 (− 0.096, 
0.032)
− 0.009 (− 0.041, 
0.023)
 + health behaviors 0.016 (− 0.038, 0.070) 0.011 (− 0.024, 0.046) 0.055 (− 0.108, 0.217)
− 0.031 (− 0.095, 
0.033)
− 0.005 (− 0.037, 
0.026)
Log GDNF [pg/mL]
− 0.037 (− 0.054, 
− 0.019)***
− 0.006 (− 0.018, 
0.007)
− 0.006 (− 0.052, 
0.040)
− 0.027 (− 0.050, 
− 0.005)*
− 0.010 (− 0.020, 
0.0004)(*)
 + ethnicity
− 0.015 (− 0.030, 
− 0.0003)*
0.002 (− 0.010, 0.014) 0.013 (− 0.033, 0.059) 0.004 (− 0.014, 0.022)
− 0.005 (− 0.016, 
0.005)
 + sex, age
− 0.013 (− 0.028, 
0.001) (*)
0.006 (− 0.006, 0.018) 0.020 (− 0.026, 0.065) 0.001 (− 0.016, 0.019)
− 0.006 (− 0.016, 
0.004)
 + comorbidities
− 0.015 (− 0.029, 
0.0003) (*)
0.007 (− 0.005, 0.018) 0.022 (− 0.024, 0.067) 0.001 (− 0.017, 0.019)
− 0.006 (− 0.016, 
0.004)
 + metabolic factors
− 0.016 (− 0.031, 
− 0.001)*
0.004 (− 0.005, 0.014) 0.020 (− 0.025, 0.064) 0.001 (− 0.017, 0.019)
− 0.006 (− 0.015, 
0.002)
 + health behaviors
− 0.016 (− 0.031, 
− 0.001)*
0.005 (− 0.004, 0.015) 0.019 (− 0.026, 0.064)
0.0005 (− 0.017, 
0.018)











 + ethnicity 0.075 (0.019, 0.130)** 0.037 (− 0.009, 0.083) 0.077 (− 0.096, 0.250) 0.023 (− 0.044, 0.090) 0.012 (− 0.027, 0.051)
 + sex, age 0.063 (0.007, 0.119)* 0.006 (− 0.038, 0.050) 0.022 (− 0.151, 0.195) 0.047 (− 0.020, 0.114) 0.022 (− 0.017, 0.060)
 + comorbidities 0.061 (0.005, 0.118)* 0.011 (− 0.033, 0.054) 0.023 (− 0.151, 0.197) 0.047 (− 0.020, 0.114) 0.022 (− 0.017, 0.061)
 + metabolic factors 0.062 (0.006, 0.118)* 0.008 (− 0.029, 0.044) 0.020 (− 0.149, 0.190) 0.051 (− 0.015, 0.117) 0.027 (− 0.006, 0.059)
 + health behaviors 0.062 (0.006, 0.118)* 0.001 (− 0.035, 0.037) 0.015 (− 0.155, 0.185) 0.055 (− 0.011, 0.121)
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nificance, with greater VWF increase in the unadjusted analysis (p = 0.002, d = 0.32). In complementary analyses, 
neurotrophins showed no significant interactions with ethnicity (data not shown).
Neurotrophic and hemostatic factors in response to stress. The regressions of stress-induced 
changes in neurotrophins on stress-induced changes in hemostatic factors, subsequently adjusted for blocks of 
covariates, are summarized in Table 5. Greater increases in both GDNF (p = 0.006, d = 0.28) (Fig. 3a) and S100B 
(p = 0.042, d = 0.21) (Fig. 3b) were significantly associated with lower VWF increase in fully adjusted models. In 
the unadjusted analysis, there also was a trend towards statistical significance for an association of greater S100B 
increase with lower fibrinogen increase (p < 0.09, d = 0.17). No significant associations were observed between 
stress changes in neurotrophins and D-dimer.
In fully adjusted complementary analyses, there emerged significant interactions between ethnicity and 
stress-induced changes in S100B for changes in fibrinogen (p = 0.041, d = 0.21) and D-dimer (p = 0.045, d = 0.21). 
Follow-up analyses revealed an inverse association between stress-induced changes in S100B and fibrinogen in 
blacks (B = − 0.315, 95% CI − 0.586, − 0.043; p = 0.023, d = 0.35), but a positive association in whites (B = 0.070, 
95% CI − 0.254, 0.393; p = 0.67). That is, a greater stress-induced change in S100B was associated with a greater 
decrease in fibrinogen in blacks but a smaller decrease in whites (Fig. 4a). Stress-induced changes in S100B and 
D-dimer showed an inverse association in whites (B = − 0.287, 95% CI − 0.721, 0.147; p = 0.19, d = 0.19) and a posi-
tive association in blacks (B = 0.238, 95% CI − 0.167, 0.643; p = 0.25, d = 0.18). That is, a stress-induced increase 
in S100B was associated with a D-dimer increase in blacks, but with a decrease in whites (Fig. 4b).
Discussion
In a cohort of black and white South Africans, we found several significant relationships between neurotrophic 
and hemostatic measures both at baseline and during acute mental stress, showing small-to-moderate effects, 
suggesting clinical relevance. Associations with a trend towards statistical significance with close to small effect 
sizes complemented the pattern of relationships. The findings of our study may support the existence of a periph-
eral neurotrophin-hemostasis interaction.
Regarding relationships at baseline, we found a significant association of lower GDNF on the one hand and of 
higher S100B on the other with higher VWF levels, both in the unadjusted and fully adjusted analyses (Fig. 1a,b), 
Figure 1.  Fully adjusted significant associations between baseline values of neurotrophins across quartiles 
(1 = lowest quartile, 4 = uppermost quartile) and stress-induced percent changes in von Willebrand factor 
(VWF). GDNF, glial cell-derived neurotrophic factor; S100B, S100 calcium-binding protein.
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suggesting a robust association. Moreover, in the unadjusted analysis, but with borderline significance only in 
the fully adjusted model, higher S100B was associated with longer CLT indicative of reduced fibrinolytic activity. 
S100B is a biomarker of cerebral injury, neuroinflammation and blood brain barrier  permeability4, and S100B 
was also found to be increased in patients with  ACS5; therefore, it is conceivable that the higher the circulating 
S100B levels, the greater the procoagulant tendency at baseline could be. Corroborating a previous study in 
trauma patients showing a direct relationship between S100B and  VWF17 and knowing that S100B may stimulate 
endothelial  cells39 secreting  VWF16, endothelial cell function could link S100B with VWF. As GDNF ensures 
survival of  neurons40, elevated levels should be associated with better health across many diseases, mirrored 
by the fact that high GDNF levels were associated with low VWF in our study. Again, endothelium-mediated 
mechanisms could be involved, as GDNF enhances tight junctions of endothelial cells of the blood brain  barrier41. 
Also, GDNF induces the differentiation of amniotic fluid-derived stem cells into vascular endothelial-like cells 
positive for  VWF42. However, the exact mechanisms through which S100B and GDNF affect hemostatic function 
in the periphery remain to be determined. Further direct associations of baseline S100B with fibrinogen, D-dimer, 
and PAI-1, and to a lesser extent of lower baseline GDNF with markers indicating impaired fibrinolysis, were 
explained by ethnicity. BDNF showed several associations with hemostatic factors, even when controlling for 
ethnicity; however, significance was lost after adjusting for sex and age. Overall, these results suggest that demo-
graphic factors are to be accounted for when studying the role of neurotrophins in baseline hemostatic function.
To study relationships between neurotrophic and hemostatic factors during sympathetic challenge, we applied 
a standard laboratory stress. Activation of the sympathetic nervous system was evidenced by marked increases in 
hemodynamic parameters. As previously reported in this  sample27, acute mental stress also provoked a significant 
increase in VWF between baseline and 10 min post-stress, whereas during this time interval fibrinogen decreased 
and D-dimer did not change. The increase in VWF concurs with abundant research showing that VWF can be 
acutely released from Weibel-Palade bodies in endothelial cells, such as through a stress-induced catecholamine 
 surge22. In contrast, the decrease in fibrinogen levels was unexpected, because acute mental stress provoked 
increased plasma fibrinogen concentrations in numerous previous studies as reviewed  elsewhere22,43,44. One 
explanation could be that a one-minute stress task was too short to induce a significant increase in fibrinogen, 
and perhaps also hemoconcentration. A hemodynamically-induced plasma shift into extravascular spaces is one 
Table 3.  Baseline values, values after stress and stress-induced percent changes in neurotrophins and 
hemostatic factors (without outliers). Values are geometric or percentage mean with 95% confidence interval 
(CI). See supplementary information for the number of outliers (i.e., 3 standard deviations above or below the 
sample mean). Two participants taking oral anticoagulants were additionally excluded for D-dimer measures.
Biological measures
All Blacks Whites
p (groups)Mean (95% CI) n Mean (95% CI) n Mean (95% CI) n
Brain-derived neurotrophic factor
Baseline [ng/mL] 1.37 (1.31, 1.44) 408 1.25 (1.16,1.34) 200 1.51 (1.42, 1.60) 208  < 0.001
Glia cell-line derived neurotrophic factor
Baseline [pg/mL] 50.8 (43.0, 59.7) 408 35.3 (28.9, 43.2) 200 71.9 (55.8, 92.7) 208  < 0.001
Stress [pg/mL] 43.2 (37.7, 49.5) 404 28.8 (24.3, 34.2) 197 63.5 (52.2, 77.3) 207  < 0.001
Change [%] − 0.04 (− 2.09, 2.00) 404 − 2.73 (− 5.43, − 0.03) 197 2.52 (− 0.52, 5.55) 207 0.011
S100 calcium-binding protein
Baseline [µg/L] 0.043 (0.041, 0.045) 406 0.050 (0.046, 0.054) 197 0.037 (0.035, 0.039) 209  < 0.001
Stress [µg/L] 0.042 (0.040, 0.043) 404 0.047 (0.044, 0.050) 196 0.038 (0.036, 0.039) 208  < 0.001
Change [%] 1.03 (0.43, 1.65) 403 2.25 (1.35, 3.14) 195 − 0.11 (− 0.89, 0.68) 208  < 0.001
von Willebrand factor
Baseline [%] 74.1 (71.9, 76.4) 407 89.3 (86.1, 92.7) 198 62.1 (60.0, 64.2) 209  < 0.001
Stress [%] 92.2 (89.1, 95.5) 408 97.2 (93.7, 100.9) 199 87.6 (82.8, 92.8) 209 0.003
Change [%] 5.44 (4.48, 6.40) 409 2.14 (1.05, 3.24) 200 8.56 (7.14, 10.03) 209  < 0.001
Fibrinogen
Baseline [g/L] 3.21 (3.14, 3.28) 409 3.41 (3.30, 3.53) 200 3.03 (2.95, 3.10) 209  < 0.001
Stress [g/L] 2.85 (2.79, 2.92) 408 2.94 (2.84, 3.04) 199 2.78 (2.69, 2.86) 209 0.014
Change [%] − 9.66 (− 10.96, − 8.36) 404 − 11.62 (− 13.45, − 9.78) 197 − 7.79 (− 9.60, − 5.98) 207 0.004
D-dimer
Baseline [ng/mL] 258 (239, 279) 402 303 (271, 339) 194 222 (200, 246) 208  < 0.001
Stress [ng/mL] 274 (250, 273) 402 330 (287, 378) 193 232 (205, 262) 209  < 0.001
Change [%] 1.20 (− 0.54, 2.93) 400 1.08 (− 1.51, 3.66) 194 1.31 (− 1.04, 3.66) 206 0.894
Plasminogen activator inhibitor-1
Baseline [ng/mL] 26.4 (25.4, 27.4) 409 34.0 (32.6, 35.3) 200 20.7 (19.8, 21.6) 209  < 0.001
Clot lysis time
Baseline [min] 79.0 (77.6, 80.4) 404 82.4 (80.2, 84.6) 195 76.0 (74.3, 77.7) 209  < 0.001
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mechanism that may underlie an increase in the plasma fibrinogen concentration during acute mental  stress45. 
Another explanation could be that speech stress, conferring social evaluative  threat46, or the combination of 
the Stroop with another stress like mental  arithmetic31 have greater potency in provoking significant fibrinogen 
responses than the Stroop  alone47. A circadian decrease during the morning hours might also explain reduced 
fibrinogen concentration, although this effect should be minimal within an 11-min period between baseline and 
stress sampling of fibrinogen measures. Explanations similar to those for the fibrinogen results could explain the 
lack of a stress-induced increase in D-dimer levels, including a minor plasma volume  shift45 with a one-minute 
stress task, and the characteristics of the stress task. D-dimer increase has particularly been shown in studies 
applying speech  stressors46,48, but not for instance when combing the Stroop with mental  arithmetic49. The vary-
ing sensitivity of the different D-dimer assays used in previous stress studies may be another explanation for 
heterogeneous study results.
Interestingly, across all study participants, we observed a significant decrease in both GDNF and S100B, the 
latter opposite to the effects of restraint stress in  rats23. However, S100B dynamics could vary between studies, as 
in the rat model S100B was measured two hours after stress, whereas in our study S100B was measured 10 min 
post-stress. To our knowledge, no studies to date have examined circulating levels of GDNF pre- and post-stress 
applying a standardized stress paradigm, so more research is needed to pinpoint with greater confidence not only 
the stress-responsiveness of GDNF but also of S100B in humans along with the involved mechanisms.
In partial agreement with our pre-specified hypothesis, lower baseline levels of BDNF were associated, on 
the one hand, with significantly greater stress-induced increases in D-dimer (Fig. 2b) and, with borderline 
significance, in VWF. Contrary to our hypothesis, there was a significantly greater decrease in fibrinogen with 
lower BDNF levels at baseline (Fig. 2a). However, as previously discussed, decreased fibrinogen levels could 
also indicate a dysfunctional stress response in our  sample27. To concur, in a previous study with healthy adults, 
smaller acute mental stress-induced fibrinogen responses were associated with a greater chance of detecting 
plasma cardiac troponin T, indicating a disadvantage for cardiovascular  health50. Therefore, the observed pat-
tern of associations could tentatively indicate that lower BDNF levels are associated with hemostatic changes 
posing a threat rather than a physiologic advantage to the cardiovascular system during sympathetic  activation20.
Unfortunately, as BDNF will likely increase during sympathetic  bursts23, we did not assess stress responses 
in BDNF, which might have yielded a different pattern of associations. To support such an argument, we found 
lower baseline levels of GDNF (Fig. 2c), but greater stress-induced increase in GDNF (Fig. 3a), both to be sig-
nificantly associated with smaller stress-induced increase in VWF. Thus, a GDNF profile of low baseline/high 
reactivity appears to be associated with low VWF response. Nonetheless, this finding could also be explained by 
the law of initial values stating that those with low baseline values GDNF are likely to demonstrate the largest 
Table 4.  Regression models for the associations between neurotrophins at baseline and stress-induced 
changes in hemostatic factors. BDNF, brain-derived neurotrophic factor; GDNF, glia cell-line derived 
neurotrophic factor; S100B, S100 calcium-binding protein B; VWF, von Willebrand factor. Unstandardized 
coefficients B (95% confidence interval) indicate the percent change from baseline in hemostatic factors with 
a 1-unit increase in (log) baseline levels of neurotrophins, subsequently adjusted for blocks of covariates. 
Significance level: (*)p < 0.10, * p < 0.05, ** p < 0.01, *** p < 0.001. Comorbidities: Human immunodeficiency 
virus positive status, history of atherothrombotic disease. Metabolic factors: Body mass index, hemoglobin 
A1c, total cholesterol to high-density lipoprotein cholesterol ratio; mean 24-h arterial pressure, estimated 
glomerular filtration rate, high-sensitivity C-reactive protein. Health behaviors: Current smoking, physical 
activity, excessive alcohol consumption.
Variables entered VWF stress change [%] Fibrinogen stress change [%] D-dimer stress change [%]
Log BDNF [ng/mL] − 3.719 (− 8.258, 0.819) 8.781 (3.106, 14.456)** − 8.872 (− 16.986, − 0.757)*
 + Ethnicity − 6.995 (− 11.335, − 2.654)** 7.353 (1.585, 13.120)* − 9.325 (− 17.607, − 1.044)*
 + Sex, age − 4.296 (− 8.803, 0.211)(*) 8.836 (2.784, 14.889)** − 11.600 (− 20.340, − 2.860)**
 + Comorbidities − 4.293 (− 8.818, 0.232)(*) 9.028 (2.968, 15.088)** − 11.298 (− 20.065, − 2.530)*
 +  Metabolic factors − 4.323 (− 8.875, 0.230)(*) 9.164 (3.107, 15.221)** − 10.528 (− 19.212, − 1.845)*
 +  Health behaviors − 3.975 (− 8.512, 0.561)(*) 9.181 (3.098, 15.263)** − 10.684 (− 19.377, − 1.992)*
Log GDNF [pg/ml] 3.033 (1.771, 4.296)*** 0.523 (− 1.133, 2.179) − 0.875 (− 3.235, 1.485)
 + Ethnicity 2.234 (0.997, 3.472)*** 0.032 (− 1.643, 1.708) − 0.949 (− 3.366, 1.468)
 +  Sex, age 1.999 (0.784, 3.214)** 0.050 (− 1.630, 1.730) − 0.854 (− 3.284, 1.577)
 +  Comorbidities 2.007 (0.784, 3.230)** 0.052 (− 1.743, 1.639) − 0.849 (− 3.282, 1.584)
 + Metabolic factors 2.092 (0.858, 3.326)*** 0.051 (− 1.647, 1.750) − 0.786 (− 3.202, 1.630)
 + Health behaviors 2.169 (0.941, 3.398)*** 0.062 (− 1.645, 1.770) − 0.909 (− 3.330, 1.512)
Log S100B [µg/L] − 7.455 (− 12.124, − 2.785)** − 8.627 (− 14.553, − 2.701)** 3.603 (− 4.870, 12.076)
 +  Ethnicity − 2.674 (− 7.396, 2.047) − 6.409 (− 12.632, − 0.186)* 3.809 (− 5.123, 12.740)
 + Sex, age − 0.600 (− 5.294, 4.095) − 6.636 (− 12.955, − 0.317)* 3.054 (− 6.069, 12.176)
 +  Comorbidities − 0.629 (− 5.346, 4.098) − 6.976 (− 13.313, − 0.639)* 3.341 (− 5.780, 12.462)
 + Metabolic factors − 0.464 (− 5.204, 4.276) − 6.593 (− 12.919, − 0.267)* 3.182 (− 5.820, 12.184)
 + Health behaviors − 0.701 (− 5.433, 4.031) − 6.419 (− 12.792, − 0.046)* 3.310 (− 5.736, 12.356)
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Figure 2.  Fully adjusted significant associations between baseline values of neurotrophins across quartiles 
(1 = lowest quartile, 4 = uppermost quartile) and stress-induced percent changes in hemostatic factors. BDNF, 
brain-derived neurotrophic factor; GDNF, glial cell-derived neurotrophic factor; S100B, S100 calcium-binding 
protein; VWF, von Willebrand factor.
Table 5.  Regression models for the associations between stress-induced changes in neurotrophins and 
hemostatic factors. GDNF, glia cell-line derived neurotrophic factor; S100B, S100 calcium-binding protein 
B; VWF, von Willebrand factor. Unstandardized beta-coefficients B (95% confidence interval) indicate the 
percent change in hemostatic factors from baseline with a 1% increase in neurotrophins from baseline, 
subsequently adjusted for blocks of covariates. Significance level: (*)p < 0.10, * p < 0.05, ** p < 0.01, *** p < 0.001. 
Comorbidities: Human immunodeficiency virus positive status, history of atherothrombotic disease. Metabolic 
factors: Body mass index, hemoglobin A1c, total cholesterol to high-density lipoprotein cholesterol ratio; 
mean 24-h arterial pressure, estimated glomerular filtration rate, high-sensitivity C-reactive protein. Health 
behaviors: Current smoking, physical activity, excessive alcohol consumption.
Variables entered VWF stress change [%] Fibrinogen stress change [%] D-dimer stress change [%]
GDNF stress change [%] − 0.044 (− 0.090, 0.003)(*) 0.011 (− 0.048, 0.069) 0.035 (− 0.049, 0.118)
 + ethnicity − 0.064 (− 0.108, − 0.020)** − 0.0003 (− 0.059, 0.058) 0.034 (− 0.050, 0.118)
 + sex, age − 0.059 (− 0.102, − 0.016)** − 0.004 (− 0.063, 0.055) 0.032 (− 0.053, 0.117)
 + comorbidities − 0.059 (− 0.102, − 0.016)** − 0.004 (− 0.062, 0.055) 0.029 (− 0.056, 0.114)
 + metabolic factors − 0.060 (− 0.103, − 0.017)** − 0.005 (− 0.064, 0.053) 0.024 (− 0.060, 0.108)
 + health behaviors − 0.060 (− 0.103, − 0.017)** − 0.006 (− 0.065, 0.052) 0.026 (− 0.058, 0.110)
S100B stress change [%] − 0.292 (− 0.447, − 0.137)*** − 0.173 (− 0.372, 0.026)(*) 0.049 (− 0.238, 0.336)
 + ethnicity − 0.200 (− 0.352, − 0.049)** − 0.123 (− 0.324, 0.078) 0.055 (− 0.237, 0.348)
 + sex, age − 0.166 (− 0.315, − 0.018)* − 0.129 (− 0.331, 0.072) 0.041 (− 0.253, 0.335)
 + comorbidities − 0.166 (− 0.315, − 0.016)* − 0.124 (− 0.327, 0.078) 0.045 (− 0.250, 0.339)
 + metabolic factors − 0.155 (− 0.307, − 0.004)* − 0.100 (− 0.304, 0.105) − 0.004 (− 0.299, 0.290)
 + health behaviors − 0.157 (− 0.308, − 0.006)* − 0.102 (− 0.308, 0.103) 0.017 (− 0.278, 0.311)
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increases. We further found that greater baseline levels of S100B was associated with greater fibrinogen decrease 
(Fig. 2d) and greater stress-induced increase in S100B was associated with smaller VWF responses (Fig. 3b). The 
significant associations that emerged during sympathetic challenge were largely unaffected by covariates. The 
association between GDNF and VWF during stress could relate to sympathetic nervous system function. GDNF 
has been shown to guide sympathetic nerves to the  heart51, and VWF is arguably one of the most responsive 
molecules to sympathetic  challenges22. In cultured astrocytes, S100B induces generation of nitric  oxide52 and 
endogenously produced NO may dampen the regulated pathway of VWF  secretion53, further underscoring a 
role of endothelial cells.
As published  earlier25–27, or to be published in more detail elsewhere, there were ethnic differences in hemo-
static factors and neurotrophins both in terms of baseline concentrations and stress reactivity. Here, we were 
particularly interested in ethnicity as a potential moderating variable in the neurotrophin-hemostasis association. 
We found that the effect of ethnicity was confined to associations between stress-induced changes in both neuro-
trophic and hemostatic factors. Greater stress-induced increase in S100B was associated with a greater fibrinogen 
decrease in blacks than whites (Fig. 4a), and with an increase in D-dimer in blacks, whereas whites showed a 
decrease (Fig. 4b). These associations do not allow a straightforward interpretation in terms of increased cardio-
vascular harm in blacks, above and beyond their apparently unfavorable metabolic and hemostatic risk profile.
The novelty of the investigated associations, a comparably large and diverse sample, taking into account 
important covariates of hemostatic function, and application of a standardized stress paradigm are strengths 
of our study, which also has its limitations. As discussed above, the short-term stress task could have prevented 
full reactivity of neurotrophins and hemostatic factors. Also, the interval between blood sampling before and 
after stress was only 11 min which could have been too short for biological measures to reach peak responses. 
Hemostatic factors like fibrinogen and D-dimer show significant time-dependent intra-individual  variation54. 
Diurnal variation has also been shown in  BDNF55, but not in  S100B56. Unfortunately, we did not include a 
non-stress control group, so we are unable to exclude potential time-dependent effects on biological measures, 
including diurnal ones. We did not have information on hematocrit and hemoglobin before and after stress to 
Figure 3.  Fully adjusted significant associations between stress-induced percent changes in neurotrophins 
across quartiles (1 = lowest quartile, 4 = uppermost quartile) and stress-induced percent changes in von 
Willebrand factor (VWF). GDNF, glial cell-derived neurotrophic factor; S100B, S100 calcium-binding protein.
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calculate stress-induced plasma volume concentration. Arithmetic adjustment of the concentration of hemostatic 
factors could have provided more insight into the mechanisms of the observed relationships between neuro-
trophins and hemostatic factors during  stress45. The cross-sectional study design precludes causal inferences, 
such that changes in hemostatic factors could also result in changes of neurotrophin levels. Residual confound-
ing by third unknown factors affecting both brain and hemostatic function cannot be excluded. This includes 
the ABO blood group for which we had no information in our study. Individuals with blood group O have an 
approximately 25% lower plasma VWF concentration. In the South African population, the frequency of blood 
group O is 45%57. However, to what extent blood group O may influence the stress-induced reactivity of VWF is 
currently unknown. Blacks differed in many health characteristics from whites, including that 9.5% of our black 
study participants were HIV-positive, but we controlled in our analyses for these differences. Nevertheless, our 
findings from a population subgroup in South Africa should not be generalized to populations with a different 
cardiovascular risk profile and ethnic composition. A range of additional metabolic factors could additionally be 
adjusted for, e.g. glucose, insulin or insulin resistance, but with the risk of overadjustment of regression models 
and multicolinearity. Whether circulating levels of neurotrophic factors reflect glial function or also originate 
considerably from extracranial sources, such as the adipose tissue in the case of  S100B58 or platelets in the case 
of  BDNF59, remains to be clarified. Platelet activity and BDNF stress reactivity were not assessed. Also, we did 
not perform global coagulation assays like the activated partial thromboplastin time or prothrombin time, 
which would have helped to better integrate the putative functional consequences of observed variations in 
VWF, fibrinogen and D-dimer concentrations on coagulability. Although effect sizes suggested clinically relevant 
Figure 4.  Fully adjusted significant association interactions between ethnicity and stress-induced percent 
change in S100 calcium-binding protein (S100B) across quartiles (1 = lowest quartile, 4 = uppermost quartile) for 
stress-induced percent changes in hemostatic factors.
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associations, we do not know the clinical implications of a peripheral neurotrophin-hemostasis link in terms of 
an increased cardiovascular risk.
To conclude, the observed associations between neurotrophic and hemostatic factors in the peripheral cir-
culation, independent of demographics, metabolic factors and health behaviors, supports a relevant role of a 
brain–heart link. The potential implications of this interaction for atherothrombotic cardiovascular disease 
need to be explored further, particularly as the effects were in the small-to-moderate range of clinical relevance.
Data availability
Deidentified individual participant data and the data analysis plan are available from the corresponding author 
on reasonable request.
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